Alpha 2.0
Login Register
» Articles » PMID: 33859918

The Effect of Thoracic Radiotherapy on the Quality of Life in Lung Cancer Patients

Overview
Journal Cureus
Specialty Biomedical Engineering
Date 2021 Apr 16
PMID 33859918
Authors
Ayfer Ay Eren
Mehmet F Eren
Sedat Koca
Affiliations
Soon will be listed here.
Abstract

Introduction This study aimed to investigate changes in respiratory symptoms and quality of life (QoL) in patients with locally advanced and metastatic lung cancer receiving thoracic radiotherapy (RT). We investigated the correlation between the level of symptom relief and tumor response. Methods Thirty-two patients were included in this study. The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life (QoL) Questionnaire (QLQ)-C30 and EORTC QLQ-LC13 were used to investigate QoL changes. Assessments were performed on the first day of RT, on the last day of RT, routinely monthly follow-ups, and three months after RT. Results The median age of the patients was 62; 88% of the patients were male. For the symptom scale, fatigue and dyspnea provided significant improvement at the end of RT (p=0.000, p=0.047). No significant improvement was observed at the end of RT in pain and insomnia. While coughing showed substantial improvement at the end of RT (p=0.004), the maximum improvement was achieved during the third-month follow-up (p<0.001). No significant improvement was observed at the end of RT in hemoptysis, but a considerable improvement was observed during the third-month follow-up (p=0.008). Conclusion This study confirms that RT offered palliation of respiratory symptoms and improved QoL in a substantial proportion of patients with lung cancer.

References
1.
Nishino M, Jackman D, Hatabu H, Yeap B, Cioffredi L, Yap J . New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy. AJR Am J Roentgenol. 2010; 195(3):W221-8. PMC: 3130298. DOI: 10.2214/AJR.09.3928. View
2.
Langendijk H, Lamers R, ten Velde G, Sanders D, de Jong J, Kessels F . Is the chest radiograph a reliable tool in the assessment of tumor response after radiotherapy in nonsmall cell lung carcinoma?. Int J Radiat Oncol Biol Phys. 1998; 41(5):1037-45. DOI: 10.1016/s0360-3016(98)00168-0. View
3.
Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S . The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer. 1995; 31A(13-14):2260-3. DOI: 10.1016/0959-8049(95)00296-0. View
4.
Hechtner M, Krause M, Konig J, Appold S, Hornemann B, Singer S . Long-term quality of life in inoperable non-small cell lung cancer patients treated with conventionally fractionated compared to hyperfractionated accelerated radiotherapy - Results of the randomized CHARTWEL trial. Radiother Oncol. 2017; 126(2):283-290. DOI: 10.1016/j.radonc.2017.12.005. View
5.
Dagnelie P, Pijls-Johannesma M, Lambin P, Beijer S, De Ruysscher D, Kempen G . Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy. Ann Oncol. 2007; 18(5):940-4. DOI: 10.1093/annonc/mdm057. View